Group Publications

G.M.Nitulescu, D.Margina, P.Juzenas, Q.Peng, O.T.Olaru, E.Saloustros, C.Fenga, D.Α.Spandidos, M.Libra, A.M.Tsatsakis (2016) Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use. Int. J. Oncol. 48(3):869-885. PubMed ID 26698230 doi:10.3892/ijo.2015.3306

S.C.Coelho, M.C.Pereira, A.Juzeniene, P.Juzenas, M.A.N.Coelho (2015) Supramolecular nanoscale assemblies for cancer diagnosis and therapy. J. Control. Rel. 213, 152-167. PubMed ID 26160308 doi:10.1016/j.jconrel.2015.06.034

R.Generalov, W.Boon Kuan, W.Chen, S.Kristensen, P.Juzenas (2015) Radiosensitizing effect of zinc oxide and silica nanocomposites on cancer cells. Colloids Surf. B: Biointerfaces 129, 79-86. PubMed ID 25829130 doi:10.1016/j.colsurfb.2015.03.026

X.Zou, M.Yao, L.Ma, M.Hossu, P.Juzenas, W.Chen (2014) X-ray induced nanoparticles based photodynamic therapy of cancer. Nanomedicine (Lond.) 9(15), 2339-2351. PubMed ID 24471504 doi:10.2217/nnm.13.198

S.C.Coelho, S.Rocha, M.C.Pereira, P.Juzenas, M.A.N.Coelho (2014) Enhancing proteasome-inhibitor effect by functionalized gold nanoparticles. J. Biomed. Nanotech. 10(4), 717-723. PubMed ID 24734524 doi:10.1166/jbn.2014.1743

S.C.Coelho, S.Rocha, P.Juzenas, P.Sampaio, G.M.Almeida, F.S.Silva, M.C.Pereira, M.A.N. Coelho (2013) Gold nanoparticle delivery-enhanced proteasome inhibitor effect in adenocarcinoma cells. Exp. Opin. Drug Deliv. 10(10), 1345-1352. PubMed ID 23937147 doi:10.1517/17425247.2013.827659

P.Juzenas, A.Kleinauskas, P.G.Luo, Y.-P.Sun (2013) Photoactivable carbon nanodots for cancer therapy. Appl. Phys. Lett. 103, ID063701 (4p). doi:10.1063/1.4817787

A.Kleinauskas, S.Rocha, S.Sahu, Y.-P.Sun, P.Juzenas (2013) Carbon-core silver-shell nanodots as sensitizers for phototherapy and radiotherapy. Nanotechnology 24(32), ID325103(10p). PubMed ID 23868054 doi:10.1088/0957-4484/24/32/325103

S.C.Coelho, S.Rocha, M.C.Pereira, M.A.N.Coelho, P.Juzenas (2013) Functionalized gold nanoparticles for drug delivery. Proceedings of the IEEE 3rd Portuguese Meeting in Bioengineering, Braga, Portugal, February 20-23, 2013 (4 p.). doi:10.1109/ENBENG.2013.6518389

A.Kleinauskas, J.-K.Kim, G.-H.Choi, H.T.Kim, K.Røe, P.Juzenas (2012) Superparamagnetic magnetite nanoparticles for cancer theranostics. Rev. Nanosci. Nanotech. 1(4), 271-283. doi:10.1166/rnn.2012.1018

A.Mikulich, S.Kavaliauskiene, P.Juzenas (2012) Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue light. Biochim. Biophys. Acta 1820(7), 870–877. PubMed ID 22507270 doi:10.1016/j.bbagen.2012.04.003

S.Steponkiene, S.Kavaliauskiene, R.Purviniene, R.Rotomskis, P.Juzenas (2011) Quantum dots affect expression of CD133 surface antigen in melanoma cells. Int. J. Nanomed. 6, 2437-2444. PubMed ID 22072879 doi:10.2147/IJN.S24477

R.Generalov, S.Kavaliauskiene, S.Westrøm, W.Chen, S.Kristensen, P.Juzenas (2011) Entrapment in phospholipid vesicles quenches photoactivity of quantum dots. Int. J. Nanomed. 6, 1875-1888. PubMed ID 21931483 doi:10.2147/IJN.S22953

I.L.Christensen, Y.-P.Sun, P.Juzenas (2011) Carbon dots as antioxidants and prooxidants. J. Biomed. Nanotech. 7(5), 667-676. PubMed ID 22195484 doi:10.1166/jbn.2011.1334

S.Rocha, R.Generalov, M.C.Pereira, P.Juzenas, M.A.N.Coelho (2011) Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Nanomedicine (Lond.) 6(1), 79-87. PubMed ID 21182420 doi:10.2217/nnm.10.101

R.Generalov, S.Lukoseviciute, A.Juzeniene, P.Juzenas (2010) Cytotoxicity and phototoxicity of red fluorescent nontargeted quantum dots. IEEE J. Select. Top. Quantum Electron. 16(4), 997-1003. doi:10.1109/JSTQE.2009.2034387

R.Generalov, I.L.Christensen, W.Chen, Y.-P.Sun, S.Kristensen, P.Juzenas (2009) Generation of singlet oxygen and other radical species by quantum dot and carbon dot nanosensitizers. In Photodynamic Therapy: Back to the Future, June 11-15, 2009, Seattle, WA, Ed. D.H.Kessel. Proc. SPIE 7380, 738072 (9 p.). doi:10.1117/12.830353

P.Juzenas, W.Chen, Y.-P.Sun, M.A.N.Coelho, R.Generalov, N.Generalova, I.L.Christensen (2008) Quantum dots and nanoparticles for photodynamic and radiation therapy of cancer. Adv. Drug Deliv. Rev. 60(15), 1600-1614 (Fig.1 selected as cover image of Dec. 2008 issue). PubMed ID 18840487 doi:10.1016/j.addr.2008.08.004

P.Juzenas, R.Generalov, A.Juzeniene, J.Moan (2008) Generation of nitrogen oxide and oxygen radicals by quantum dots. J. Biomed. Nanotech. 4(4), 450–456. doi:10.1166/jbn.2008.008

Publications by Petras Juzenas

84 publications found

Publications 2023

  1. Espeland K, Kleinauskas A, Juzenas P, Darvekar S, Vasovic V, Warloe T, Christensen E, Jahnsen J, Peng Q (2023)
    Photodynamic Effects with 5-Aminolevulinic Acid on Cytokines and Exosomes in Human Peripheral Blood Mononuclear Cells from Patients with Crohn's Disease
    Int J Mol Sci, 24 (5)
    DOI 10.3390/ijms24054554, PubMed 36901982

Publications 2022

  1. Desgranges S, Juzenas P, Vasovic V, Gederaas OA, Lindgren M, Warloe T, Peng Q, Contino-Pépin C (2022)
    Amphiphilic Protoporphyrin IX Derivatives as New Photosensitizing Agents for the Improvement of Photodynamic Therapy
    Biomedicines, 10 (2)
    DOI 10.3390/biomedicines10020423, PubMed 35203632
  2. Espeland K, Kleinauskas A, Juzenas P, Brech A, Darvekar S, Vasovic V, Warloe T, Christensen E, Jahnsen J, Peng Q (2022)
    Photodynamic Effects with 5-Aminolevulinic Acid on Cytokines and Exosomes in Human Peripheral Blood Mononuclear Cells
    Biomedicines, 10 (2)
    DOI 10.3390/biomedicines10020232, PubMed 35203441

Publications 2021

  1. Christensen E, Foss OA, Quist-Paulsen P, Staur I, Pettersen F, Holien T, Juzenas P, Peng Q (2021)
    Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study
    Pharmaceutics, 13 (10)
    DOI 10.3390/pharmaceutics13101558, PubMed 34683851
  2. Sioud M, Juzenas P, Zhang Q, Kleinauskas A, Peng Q (2021)
    Evaluation of In Vitro Phototoxicity of a Minibody-IR700 Conjugate Using Cell Monolayer and Multicellular Tumor Spheroid Models
    Cancers (Basel), 13 (13)
    DOI 10.3390/cancers13133356, PubMed 34283089
  3. Sioud M, Juzenas P, Zhang Q, Kleinauskas A, Peng Q (2021)
    Correction: Sioud et al. Evaluation of In Vitro Phototoxicity of a Minibody-IR700 Conjugate Using Monolayer and Multicellular Tumor Spheroid Models. Cancers 2021, 13, 3356
    Cancers (Basel), 13 (21)
    DOI 10.3390/cancers13215513, PubMed 34771754
  4. Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
    Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094815, PubMed 34062920

Publications 2020

  1. Darvekar S, Juzenas P, Oksvold M, Kleinauskas A, Holien T, Christensen E, Stokke T, Sioud M, Peng Q (2020)
    Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis
    Cancers (Basel), 12 (2)
    DOI 10.3390/cancers12020377, PubMed 32041351
  2. Mastrangelopoulou M, Grigalavicius M, Raabe TH, Skarpen E, Juzenas P, Peng Q, Berg K, Theodossiou TA (2020)
    Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances
    Cancer Rep (Hoboken), 5 (12), e1278
    DOI 10.1002/cnr2.1278, PubMed 32737955

Publications 2018

  1. Nitulescu GM, Van De Venter M, Nitulescu G, Ungurianu A, Juzenas P, Peng Q, Olaru OT, Grădinaru D, Tsatsakis A, Tsoukalas D, Spandidos DA, Margina D (2018)
    The Akt pathway in oncology therapy and beyond (Review)
    Int J Oncol, 53 (6), 2319-2331
    DOI 10.3892/ijo.2018.4597, PubMed 30334567

Publications 2017

  1. Hauge S, Naucke C, Hasvold G, Joel M, Rødland GE, Juzenas P, Stokke T, Syljuåsen RG (2017)
    Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading
    Oncotarget, 8 (7), 10966-10979
    DOI 10.18632/oncotarget.14089, PubMed 28030798

Publications 2015

  1. Coelho SC, Pereira MC, Juzeniene A, Juzenas P, Coelho MAN (2015)
    Supramolecular nanoscale assemblies for cancer diagnosis and therapy
    J Control Release, 213, 152-167
    DOI 10.1016/j.jconrel.2015.06.034, PubMed 26160308
  2. Generalov R, Kuan WB, Chen W, Kristensen S, Juzenas P (2015)
    Radiosensitizing effect of zinc oxide and silica nanocomposites on cancer cells
    Colloids Surf B Biointerfaces, 129, 79-86
    DOI 10.1016/j.colsurfb.2015.03.026, PubMed 25829130
  3. Nitulescu GM, Margina D, Juzenas P, Peng Q, Olaru OT, Saloustros E, Fenga C, Spandidos DΑ, Libra M, Tsatsakis AM (2015)
    Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
    Int J Oncol, 48 (3), 869-85
    DOI 10.3892/ijo.2015.3306, PubMed 26698230

Publications 2014

  1. Coelho SC, Rocha S, Pereira MC, Juzenas P, Coelho MA (2014)
    Enhancing proteasome-lnhibitor effect by functionalized gold nanoparticles
    J Biomed Nanotechnol, 10 (4), 717-23
    DOI 10.1166/jbn.2014.1743, PubMed 24734524
  2. Zou X, Yao M, Ma L, Hossu M, Han X, Juzenas P, Chen W (2014)
    X-ray-induced nanoparticle-based photodynamic therapy of cancer
    Nanomedicine (Lond), 9 (15), 2339-51
    DOI 10.2217/nnm.13.198, PubMed 24471504

Publications 2013

  1. Coelho SC, Rocha S, Juzenas P, Sampaio P, Almeida GM, Silva FS, Pereira MC, Coelho MA (2013)
    Gold nanoparticle delivery-enhanced proteasome inhibitor effect in adenocarcinoma cells
    Expert Opin Drug Deliv, 10 (10), 1345-52
    DOI 10.1517/17425247.2013.827659, PubMed 23937147
  2. Juzenas P, Kleinauskas A, Luo PG, Sun YP (2013)
    Photoactivatable carbon nanodots for cancer therapy
    Appl. Phys. Lett., 103 (6), 063701
    DOI 10.1063/1.4817787
  3. Kleinauskas A, Rocha S, Sahu S, Sun YP, Juzenas P (2013)
    Carbon-core silver-shell nanodots as sensitizers for phototherapy and radiotherapy
    Nanotechnology, 24 (32), 325103
    DOI 10.1088/0957-4484/24/32/325103, PubMed 23868054

Publications 2012

  1. Mikulich A, Kavaliauskiene S, Juzenas P (2012)
    Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue light
    Biochim Biophys Acta, 1820 (7), 870-7
    DOI 10.1016/j.bbagen.2012.04.003, PubMed 22507270

Publications 2011

  1. Christensen IL, Sun YP, Juzenas P (2011)
    Carbon dots as antioxidants and prooxidants
    J Biomed Nanotechnol, 7 (5), 667-76
    DOI 10.1166/jbn.2011.1334, PubMed 22195484
  2. Generalov R, Kavaliauskiene S, Westrøm S, Chen W, Kristensen S, Juzenas P (2011)
    Entrapment in phospholipid vesicles quenches photoactivity of quantum dots
    Int J Nanomedicine, 6, 1875-88
    DOI 10.2147/IJN.S22953, PubMed 21931483
  3. Rocha S, Generalov R, Pereira Mdo C, Peres I, Juzenas P, Coelho MA (2011)
    Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention
    Nanomedicine (Lond), 6 (1), 79-87
    DOI 10.2217/nnm.10.101, PubMed 21182420
  4. Steponkiene S, Kavaliauskiene S, Purviniene R, Rotomskis R, Juzenas P (2011)
    Quantum dots affect expression of CD133 surface antigen in melanoma cells
    Int J Nanomedicine, 6, 2437-44
    DOI 10.2147/IJN.S24477, PubMed 22072879

Publications 2010

  1. Generalov R, Lukoseviciute S, Juzeniene A, Juzenas P (2010)
    Cytotoxicity and Phototoxicity of Red Fluorescent Nontargeted Quantum Dots
    IEEE J. Sel. Top. Quantum Electron., 16 (4), 997-1003
    DOI 10.1109/JSTQE.2009.2034387
  2. Juzenas P, Juzeniene A (2010)
    Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors
    Photodiagnosis Photodyn Ther, 7 (3), 152-7
    DOI 10.1016/j.pdpdt.2010.06.003, PubMed 20728838
  3. Juzeniene A, Juzenas P, Iani V, Moan J (2010)
    Reflectance spectroscopy and fluorescein angiography applied to assess photodynamic response in healthy mouse skin treated with topical hexylaminolevulinate
    Photodiagnosis Photodyn Ther, 7 (4), 239-45
    DOI 10.1016/j.pdpdt.2010.07.001, PubMed 21112546
  4. Juzeniene A, Juzenas P, Moan J (2010)
    Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo
    Methods Mol Biol, 635, 97-106
    DOI 10.1007/978-1-60761-697-9_7, PubMed 20552342
  5. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
    Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses
    J Pharm Sci, 99 (8), 3486-98
    DOI 10.1002/jps.22116, PubMed 20222026
  6. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
    Novel patch-based systems for the localised delivery of ALA-esters
    J Photochem Photobiol B, 101 (1), 59-69
    DOI 10.1016/j.jphotobiol.2010.06.012, PubMed 20634088
  7. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
    Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches
    J Pharm Pharmacol, 62 (6), 685-95
    DOI 10.1211/jpp.62.06.0004, PubMed 20636855
  8. Petrosiute S, Purvinene R, Pasukoniene V, Lukoseviciute S, Juzenas P, Rotomskis R (2010)
    CHARACTERIZATION OF CANCER STEM CELLS AND THEIR RESPONSE TO CdTe QUANTUM DOTS
    MED PHYS BALTIC STAT (2), 71-+
  9. Petrosiute S, Purviniene R, Pasukoniene V, Lukosevciute S, Juzenas P, Rotomskis R (2010)
    Characterization of cancer stem cells and their response to CdTe quantum dots
    Med Phys Balt Stat, 8, 71-76
    PublikaID 41

Publications 2009

  1. Donnelly RF, McCarron PA, Al-Kassas R, Juzeniene A, Juzenas P, Iani V, Woolfson AD, Moan J (2009)
    Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles
    Biopharm Drug Dispos, 30 (2), 55-70
    DOI 10.1002/bdd.645, PubMed 19226650
  2. Generalov R, Christensen IL, Chen W, Sun YP, Kristensen S, Juzenas P (2009)
    Generation of singlet oxygen and other radical species by quantum dot and carbon dot nanosensitizers
    PROC SPIE, 7380, 738072
    DOI 10.1117/12.830353

Publications 2008

  1. Donnelly RF, Morrow DI, McCarron PA, David Woolfson A, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2008)
    Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer
    Photochem Photobiol, 85 (1), 195-204
    DOI 10.1111/j.1751-1097.2008.00417.x, PubMed 18764907
  2. Donnelly RF, Morrow DI, McCarron PA, Woolfson AD, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2008)
    Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy
    J Control Release, 129 (3), 154-62
    DOI 10.1016/j.jconrel.2008.05.002, PubMed 18556084
  3. Juzenas P, Chen W, Sun YP, Coelho MA, Generalov R, Generalova N, Christensen IL (2008)
    Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer
    Adv Drug Deliv Rev, 60 (15), 1600-14
    DOI 10.1016/j.addr.2008.08.004, PubMed 18840487
  4. Juzenas P, Generalov R, Juzeniene A, Moan J (2008)
    Generation of Nitrogen Oxide and Oxygen Radicals by Quantum Dots
    J. Biomed. Nanotechnol., 4 (4), 450-456
    DOI 10.1166/jbn.2008.008
  5. Juzenas P, Juzeniene A, Iani V, Moan J (2008)
    Depth profile of protoporphyrin IX fluorescence in an amelanotic mouse melanoma model
    Photochem Photobiol, 85 (3), 760-4
    DOI 10.1111/j.1751-1097.2008.00496.x, PubMed 19140894

Publications 2007

  1. Bugaj A, Kwitniewski M, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2007)
    Photodynamic therapy with di-l-arginine protoporphyrinate on WiDr human colon adenocarcinoma xenografts in athymic nude mice
    Photodiagnosis Photodyn Ther, 4 (4), 237-41
    DOI 10.1016/j.pdpdt.2007.08.001, PubMed 25047558
  2. Juzeniene A, Juzenas P, Iani V, Moan J (2007)
    Topical applications of iron chelators in photosensitization
    Photochem Photobiol Sci, 6 (12), 1268-74
    DOI 10.1039/b703861e, PubMed 18046481
  3. Kaliszewski M, Kwasny M, Juzeniene A, Juzenas P, Graczyk A, Ma LW, Iani V, Mikolajewska P, Moan J (2007)
    Biological activity of 5-aminolevulinic acid and its methyl ester after storage under different conditions
    J Photochem Photobiol B, 87 (2), 67-72
    DOI 10.1016/j.jphotobiol.2007.01.003, PubMed 17350278

Publications 2006

  1. Bugaj A, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2006)
    The effect of dimethylsulfoxide, 1-[2-(decylthio)ethyl]azacyclopentan-2-one and Labrafac(®)CC on porphyrin formation in normal mouse skin during topical application of methyl 5-aminolevulinate: A fluorescence and extraction study
    Photodiagnosis Photodyn Ther, 3 (1), 27-33
    DOI 10.1016/S1572-1000(05)00109-2, PubMed 25049025
  2. Bugaj A, Juzeniene A, Juzenas P, Iani V, Ma LW, Moan J (2006)
    The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid
    J Photochem Photobiol B, 83 (2), 94-7
    DOI 10.1016/j.jphotobiol.2005.12.003, PubMed 16442808
  3. Donnelly RF, Juzenas P, McCarron PA, Ma LW, Woolfson AD, Moan J (2006)
    Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo
    Photodiagnosis Photodyn Ther, 3 (3), 190-201
    DOI 10.1016/j.pdpdt.2006.03.007, PubMed 25049154
  4. Donnelly RF, Ma LW, Juzenas P, Iani V, McCarron PA, Woolfson AD, Moan J (2006)
    Topical bioadhesive patch systems enhance selectivity of protoporphyrin IX accumulation
    Photochem Photobiol, 82 (3), 670-5
    DOI 10.1562/2005-08-08-RA-641, PubMed 16475870
  5. Juzenas P, Juzeniene A, Iani V, Moan J (2006)
    The influence of light and darkness on cutaneous fluorescence in mice
    Luminescence, 21 (3), 159-63
    DOI 10.1002/bio.900, PubMed 16502394
  6. Juzeniene A, Juzenas P, Bronshtein I, Vorobey A, Moan J (2006)
    The influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid
    J Photochem Photobiol B, 84 (2), 161-6
    DOI 10.1016/j.jphotobiol.2006.02.009, PubMed 16624569
  7. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2006)
    Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin
    Br J Dermatol, 155 (4), 791-9
    DOI 10.1111/j.1365-2133.2006.07484.x, PubMed 16965430
  8. McCarron PA, Ma LW, Juzenas P, Lani V, Woolfson A, Zawislak AA, Moan J (2006)
    Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems
    J Environ Pathol Toxicol Oncol, 25 (1-2), 389-402
    DOI 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.240, PubMed 16566730
  9. Moan J, Juzenas P (2006)
    Singlet oxygen in photosensitization
    J Environ Pathol Toxicol Oncol, 25 (1-2), 29-50
    DOI 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.30, PubMed 16566709
  10. Veberg A, Sørheim O, Moan J, Iani V, Juzenas P, Nilsen AN, Wold JP (2006)
    Measurement of lipid oxidation and porphyrins in high oxygen modified atmosphere and vacuum-packed minced turkey and pork meat by fluorescence spectra and images
    Meat Sci, 73 (3), 511-20
    DOI 10.1016/j.meatsci.2006.02.001, PubMed 22062491
  11. Zhao L, Nielsen KP, Juzeniene A, Juzenas P, Lani V, Ma LW, Stamnes K, Stamnes JJ, Moan J (2006)
    Spectroscopic measurements of photoinduced processes in human skin after topical application of the hexyl ester of 5-aminolevulinic acid
    J Environ Pathol Toxicol Oncol, 25 (1-2), 307-20
    DOI 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.200, PubMed 16566726

Publications 2005

  1. Donnelly RF, Morrow DI, McCarron PA, Juzenas P, Woolfson AD (2005)
    Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues
    J Photochem Photobiol B, 82 (1), 59-71
    DOI 10.1016/j.jphotobiol.2005.08.007, PubMed 16242952
  2. Juzenas P, Juzeniene A, Moan J (2005)
    Deferoxamine photosensitizes cancer cells in vitro
    Biochem Biophys Res Commun, 332 (2), 388-91
    DOI 10.1016/j.bbrc.2005.04.138, PubMed 15910749
  3. Kaliszewski M, Juzeniene A, Juzenas P, Kwasny M, Kaminski J, Dabrowski Z, Golinski J, Moan J (2005)
    Formation of protoporphyrin IX from carboxylic- and amino-derivatives of 5-aminolevulinic acid
    Photodiagnosis Photodyn Ther, 2 (2), 129-34
    DOI 10.1016/S1572-1000(05)00012-8, PubMed 25048672
  4. Kristiansson S, Juzeniene A, Juzenas P, Iani V, Löfgren L, Moan J (2005)
    Kinetics of protoporphyrin IX formation in rat oral mucosa and skin after application of 5-aminolevulinic acid and its methylester
    Photochem Photobiol, 81 (2), 394-7
    DOI 10.1562/2004-04-02-RA-132, PubMed 15535733
  5. Luksiene Z, Juzenas P, Moan J (2005)
    Radiosensitization of tumours by porphyrins
    Cancer Lett, 235 (1), 40-7
    DOI 10.1016/j.canlet.2005.03.041, PubMed 15946797
  6. Nielsen KP, Juzeniene A, Juzenas P, Stamnes K, Stamnes JJ, Moan J (2005)
    Choice of optimal wavelength for PDT: the significance of oxygen depletion
    Photochem Photobiol, 81 (5), 1190-4
    DOI 10.1562/2005-04-06-RA-478, PubMed 15934793
  7. Wold JP, Veberg A, Nilsen A, Iani V, Juzenas P, Moan J (2005)
    The role of naturally occurring chlorophyll and porphyrins in light-induced oxidation of dairy products. A study based on fluorescence spectroscopy and sensory analysis
    Int. Dairy J., 15 (4), 343-353
    DOI 10.1016/j.idairyj.2004.08.009

Publications 2004

  1. Juzenas P, Juzeniene A, Rotomskis R, Moan J (2004)
    Spectroscopic evidence of monomeric aluminium phthalocyanine tetrasulphonate in aqueous solutions
    J Photochem Photobiol B, 75 (1-2), 107-10
    DOI 10.1016/j.jphotobiol.2004.05.011, PubMed 15246357
  2. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2004)
    Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy
    Lasers Med Sci, 19 (3), 139-49
    DOI 10.1007/s10103-004-0314-x, PubMed 15503248
  3. Nielsen KP, Lu Z, Juzenas P, Stamnes JJ, Stamnes K, Moan J (2004)
    Reflectance spectra of pigmented and nonpigmented skin in the UV spectral region
    Photochem Photobiol, 80 (3), 450-5
    DOI 10.1562/0031-8655(2004)080<0450:RSOPAN>2.0.CO;2, PubMed 15623329
  4. Uzdensky A, Kolpakova E, Juzeniene A, Juzenas P, Moan J (2004)
    The effect of sub-lethal ALA-PDT on the cytoskeleton and adhesion of cultured human cancer cells
    Biochim Biophys Acta, 1722 (1), 43-50
    DOI 10.1016/j.bbagen.2004.11.011, PubMed 15716135
  5. Uzdensky AB, Juzeniene A, Kolpakova E, Hjortland GO, Juzenas P, Moan J (2004)
    Photosensitization with protoporphyrin IX inhibits attachment of cancer cells to a substratum
    Biochem Biophys Res Commun, 322 (2), 452-7
    DOI 10.1016/j.bbrc.2004.07.132, PubMed 15325251

Publications 2003

  1. Moan J, Ma LW, Juzeniene A, Iani V, Juzenas P, Apricena F, Peng Q (2003)
    Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters
    Int J Cancer, 103 (1), 132-5
    DOI 10.1002/ijc.10802, PubMed 12455066

Publications 2002

  1. Bissonnette R, Tremblay JF, Juzenas P, Boushira M, Lui H (2002)
    Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques
    J Invest Dermatol, 119 (1), 77-83
    DOI 10.1046/j.1523-1747.2002.01827.x, PubMed 12164928
  2. Juzenas P, Juzeniene A, Kaalhus O, Iani V, Moan J (2002)
    Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo
    Photochem Photobiol Sci, 1 (10), 745-8
    DOI 10.1039/b203459j, PubMed 12656473
  3. Juzenas P, Juzeniene A, Stakland S, Iani V, Moan J (2002)
    Photosensitizing effect of protoporphyrin IX in pigmented melanoma of mice
    Biochem Biophys Res Commun, 297 (3), 468-72
    DOI 10.1016/s0006-291x(02)02238-6, PubMed 12270116
  4. Juzenas P, Sharfaei S, Moan J, Bissonnette R (2002)
    Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester
    J Photochem Photobiol B, 67 (1), 11-7
    DOI 10.1016/s1011-1344(02)00269-5, PubMed 12007462
  5. Juzeniene A, Juzenas P, Iani V, Moan J (2002)
    Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model
    Photochem Photobiol, 76 (3), 329-34
    DOI 10.1562/0031-8655(2002)076<0329:taoaaa>2.0.co;2, PubMed 12403455
  6. Juzeniene A, Juzenas P, Kaalhus O, Iani V, Moan J (2002)
    Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin
    Photochem Photobiol, 76 (4), 452-6
    DOI 10.1562/0031-8655(2002)076<0452:teoaop>2.0.co;2, PubMed 12405155
  7. Juzeniene A, Ma LW, Juzenas P, Iani V, Lange N, Moan J (2002)
    Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo
    Cell Mol Biol (Noisy-le-grand), 48 (8), 911-6
    PubMed 12699250
  8. Sharfaei S, Juzenas P, Moan J, Bissonnette R (2002)
    Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice
    Arch Dermatol Res, 294 (5), 237-42
    DOI 10.1007/s00403-002-0320-4, PubMed 12115027

Publications 2001

  1. Juzenas P, Iani V, Bagdonas S, Rotomskis R, Moan J (2001)
    Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light
    J Photochem Photobiol B, 61 (1-2), 78-86
    DOI 10.1016/s1011-1344(01)00149-x, PubMed 11485851
  2. Moan J, Ma LW, Iani V, Juzenas P (2001)
    Mechanisms and procedures in PDT
    SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, 641-647
  3. Moan J, Van den Akker JTHM, Juzenas P, Ma LW, Angell-Petersen E, Gadmar OB, Iani V (2001)
    On the basis for tumor selectivity in the 5-aminolevulinic acid-induced synthesis of protoporphyrin IX
    J. Porphyr. Phthalocyanines, 5 (2), 170-176
    DOI 10.1002/jpp.329
  4. von Beckerath M, Juzenas P, Ma LW, Iani V, Löfgren L, Moan J (2001)
    The influence of UV exposure on 5-aminolevulinic acid-induced protoporphyrin IX production in skin
    Photochem Photobiol, 74 (6), 825-8
    DOI 10.1562/0031-8655(2001)074<0825:tioueo>2.0.co;2, PubMed 11783939

Publications 2000

  1. Bagdonas S, Ma LW, Iani V, Rotomskis R, Juzenas P, Moan J (2000)
    Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study
    Photochem Photobiol, 72 (2), 186-92
    DOI 10.1562/0031-8655(2000)072<0186:poaaip>2.0.co;2, PubMed 10946571

Publications 1999

  1. Juzenas P, Sorensen R, Iani V, Moan J (1999)
    Clearance of protoporphyrin IX from mouse skin after topical application of 5-aminolevulinic acid and its methyl ester
    P SOC PHOTO-OPT INS, 3563, 161-166
    DOI 10.1117/12.339134
  2. Juzenas P, Sørensen R, Iani V, Moan J (1999)
    Uptake of topically applied 5-aminolevulinic acid and production of protoporphyrin IX in normal mouse skin: dependence on skin temperature
    Photochem Photobiol, 69 (4), 478-81
    DOI 10.1111/j.1751-1097.1999.tb03315.x, PubMed 10212580
  3. Moan J, Berg K, Gadmar OB, Iani V, Ma L, Juzenas P (1999)
    The temperature dependence of protoporphyrin IX production in cells and tissues
    Photochem Photobiol, 70 (4), 669-73
    DOI 10.1111/j.1751-1097.1999.tb08268.x, PubMed 10546563
  4. Sorensen R, Juzenas P, Iani V, Moan J (1999)
    Formation of protoporphyrin IX in mouse skin after topical application of 5-aminolevulinic acid and its methyl ester.
    P SOC PHOTO-OPT INS, 3563, 77-81
    DOI 10.1117/12.339121
 
Dec 29, 2015 Page visits: 6468
Scroll to top